RxDoctor Payments Data

Allan Mendell

Child & Adolescent Psychiatry · Nashua, NHNPI 1598704025

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 43.5% of the total.

$2,068in general payments, 2019–2025

Across 145 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$900
  • Sunovion Pharmaceuticals Inc.$286
  • Vanda Pharmaceuticals Inc.$204
  • Takeda Pharmaceuticals U.S.A., Inc.$164
  • Johnson & Johnson$90
  • Otsuka America Pharmaceutical, Inc.$67
  • plus $357 from 10 others

What the payments were for

  • Food & beverage$2,065100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few child & adolescent psychiatry providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Other child & adolescent psychiatry in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →